Idea EngineIdea EngineNASDAQ:COSM Cosmos Health (COSM) Stock Price, News & Analysis $0.25 +0.04 (+18.57%) As of 12:55 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cosmos Health Stock (NASDAQ:COSM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cosmos Health alerts:Sign Up Key Stats Today's Range$0.19▼$0.2450-Day Range$0.21▼$0.4152-Week Range$0.19▼$1.32Volume85.59 million shsAverage Volume1.97 million shsMarket Capitalization$15.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. Read More Cosmos Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreCOSM MarketRank™: Cosmos Health scored higher than 44% of companies evaluated by MarketBeat, and ranked 637th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingCosmos Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCosmos Health has received no research coverage in the past 90 days.Read more about Cosmos Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cosmos Health are expected to grow in the coming year, from ($0.06) to $0.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cosmos Health is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cosmos Health is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCosmos Health has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cosmos Health's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.01% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 0.82, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently decreased by 8.85%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCosmos Health does not currently pay a dividend.Dividend GrowthCosmos Health does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.92 News SentimentCosmos Health has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for Cosmos Health this week, compared to 5 articles on an average week.Search Interest3 people have searched for COSM on MarketBeat in the last 30 days. MarketBeat Follows8 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. Company Ownership3.7 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $207,207.00 in company stock, which represents 1.4575% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Cosmos Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $207,207.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders26.15% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.61% of the stock of Cosmos Health is held by institutions.Read more about Cosmos Health's insider trading history. Receive COSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cosmos Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COSM Stock News HeadlinesCosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit3 hours ago | globenewswire.comCosmos Health Inc.: Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M ...June 13 at 8:26 AM | finanznachrichten.deRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.June 15 at 1:00 AM | Porter & Company (Ad)Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5 ...June 13 at 8:26 AM | markets.businessinsider.comGrigorios Siokas Purchases 218,447 Shares of Cosmos Health (NASDAQ:COSM) StockJune 13 at 7:39 AM | insidertrades.comCosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of MedicinesJune 12 at 3:33 PM | globenewswire.comCosmos Health Stock (COSM) Opinions on EU Expansion and Antiseptic Sales GrowthJune 12 at 1:51 PM | quiverquant.comQCosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross ProfitJune 12 at 9:29 AM | globenewswire.comSee More Headlines COSM Stock Analysis - Frequently Asked Questions How have COSM shares performed this year? Cosmos Health's stock was trading at $0.4980 on January 1st, 2026. Since then, COSM shares have decreased by 54.0% and is now trading at $0.2290. How were Cosmos Health's earnings last quarter? Cosmos Health Inc. (NASDAQ:COSM) posted its quarterly earnings data on Thursday, May, 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). The business had revenue of $18.40 million for the quarter, compared to analysts' expectations of $17.93 million. Cosmos Health had a negative trailing twelve-month return on equity of 52.85% and a negative net margin of 30.41%. When did Cosmos Health's stock split? Cosmos Health's stock reverse split on the morning of Thursday, December 15th 2022.The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. Who are Cosmos Health's major shareholders? Top institutional investors of Cosmos Health include Renaissance Technologies LLC (0.75%). Insiders that own company stock include Grigorios Siokas and Georgios Terzis. View institutional ownership trends. How do I buy shares of Cosmos Health? Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cosmos Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR). Company Calendar Last Earnings5/21/2026Today6/15/2026Next Earnings (Estimated)8/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 COSM's financial health is in the Red zone, according to TradeSmith. COSM has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryWholesale Current SymbolNASDAQ:COSM CIK1474167 Webwww.cosmosholdingsinc.com Phone(312) 536-3102FaxN/AEmployees100Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.15 million Net Margins-30.41% Pretax Margin-30.41% Return on Equity-52.85% Return on Assets-17.87% Debt Debt-to-Equity Ratio0.31 Current Ratio1.08 Quick Ratio0.92 Sales & Book Value Annual Sales$65.27 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book0.51Miscellaneous Outstanding Shares62,080,000Free Float45,845,000Market Cap$14.22 million OptionableOptionable Beta4.80 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:COSM) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmos Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cosmos Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
